Movement Disorders

January 16, 2021

The chief medical officer of Cerevel Therapeutics detailed phase 2 data of its investigational agent tavapadon, which has been studied in patients with Parkinson disease.

January 15, 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 15, 2021.

January 13, 2021

Men were observed to derive benefit from a Greek Mediterranean diet and women were found to generally adhere more closely to diet interventions than men.

January 13, 2021

The clinical fellow at Massachusetts General Hospital detailed his research on neurology resident EEG education, and the increased need for more consistency throughout programs.

January 12, 2021

The executive director of the Norman Fixel Institute for Neurological Diseases gave his call-to-action on how to change the approval system for neurologic devices for rare diseases.

January 11, 2021

Here's what is coming soon to NeurologyLive.

January 10, 2021

The chief medical officer of Cerevel Therapeutics detailed the TEMPO trials, a trio of studies that will examine tavapadon in patients with early and late-stage Parkinson disease.

January 08, 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 8, 2021.

January 07, 2021

Andrea Quattrone, MD, discusses how his team worked to create a simpler biomarker after developing MRPI 2.0.

January 06, 2021

The chief medical officer of CND Life Sciences and medical director of Honor Health Neurology spoke to the role synuclein has played in advancing PD diagnosis.